These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Pharmacotherapy of rheumatic diseases]. Gaja A; Vykydal M Acta Univ Palacki Olomuc Fac Med; 1985; 108():295-300. PubMed ID: 3161288 [No Abstract] [Full Text] [Related]
44. [Clinical studies in the field of degenerative joint diseases with a phenylalcanoic derivative]. Manfredi GC Minerva Med; 1973; 64(48):2561-4. PubMed ID: 4580158 [No Abstract] [Full Text] [Related]
45. [A new anti-inflammatory treatment]. Amor B; de Gery A; Delbarre F Therapeutique; 1972 Nov; 48(9):595-7. PubMed ID: 4539841 [No Abstract] [Full Text] [Related]
46. The mechanism of action of antirheumatic agents. Mathies H Triangle; 1979; 18(2-3):63-73. PubMed ID: 44578 [No Abstract] [Full Text] [Related]
47. Rational use of analgesics in the treatment of the rheumatic disorders. Hart FD Drugs; 1987 Jan; 33(1):85-93. PubMed ID: 2880705 [TBL] [Abstract][Full Text] [Related]
48. [Drug therapy of inflammatory rheumatic diseases]. Keitel W Z Arztl Fortbild (Jena); 1987; 81(9):439-41. PubMed ID: 3498268 [No Abstract] [Full Text] [Related]
49. A survey of clinical trials with fenbufen. Mawdsley P Arzneimittelforschung; 1980; 30(4A):740-6. PubMed ID: 7002163 [TBL] [Abstract][Full Text] [Related]
50. [Current problems of treatment of inflammatory rheumatic diseases]. Nasonova VA Ter Arkh; 1981; 53(7):3-6. PubMed ID: 6974909 [No Abstract] [Full Text] [Related]
51. The long-term benefits of ibuprofen in rheumatological practice. Interim report. Goldberg AA; Hall JE; Buckler JW; Dodsworth PG Practitioner; 1971 Sep; 207(239):343-8. PubMed ID: 5095841 [No Abstract] [Full Text] [Related]
52. [Clinical trial treatment with oral parazolidin tablets in the Orthopedic Hospital Pretoria]. de Wet IS S Afr Med J; 1967 Jun; 41(23):581-2. PubMed ID: 6028820 [No Abstract] [Full Text] [Related]
53. [Use of antirheumatic agents and analgesics in old age in chronic rheumatic disorders]. Apostoloff E Z Arztl Fortbild (Jena); 1982 Apr; 76(8):328-30. PubMed ID: 6981261 [No Abstract] [Full Text] [Related]
54. The use of drugs in rheumatic diseases. Gall EP Prim Care; 1984 Jun; 11(2):369-80. PubMed ID: 6433371 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic and therapeutic effects of ketoprofen. Sala G; Silvestri N; Castegnaro E; Pollini C Farmaco Prat; 1978 Oct; 33(10):455-60. PubMed ID: 312213 [No Abstract] [Full Text] [Related]
57. [Rheumatic manifestations--when and how to treat?]. Schattenkirchner M Verh Dtsch Ges Inn Med; 1990; 96():95-105. PubMed ID: 2092519 [No Abstract] [Full Text] [Related]
58. Multicentre trial of piroxicam in ambulant rheumatology. Alvart R Eur J Rheumatol Inflamm; 1983; 6(1):99-105. PubMed ID: 6602706 [TBL] [Abstract][Full Text] [Related]
59. [A new anti-inflammatory agent: calcium bucloxate in pediatrics]. Debray H; Galland A Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1440-2. PubMed ID: 4548650 [No Abstract] [Full Text] [Related]
60. [Anti-rheumatic drugs or the drug therapy of rheumatic diseases]. Gross D Ther Umsch; 1972 Aug; 29(8):461. PubMed ID: 4538296 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]